Novel targets detected by next generation sequencing among triple refractory patients can be clinically targetable | AVESİS

Ankara University Research Information System

Novel targets detected by next generation sequencing among triple refractory patients can be clinically targetable

Copy For Citation

CENGİZ SEVAL G., KUZU I., Yüksel S., YILMAZ H., Yavuz G., KAYGUSUZ G., ...More

19th International Myeloma Society Annual Meeting, 25 August 2022, (Full Text)

Publication Type: Conference Paper / Full Text
Ankara University Affiliated: Yes